Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. M. Almeida, M. Prado e Silva, S. F. Soto, A. T. Correia, P. Pêgo-Fernandes, R. Pazetti (São Paulo, Brazil). Tacrolimus increases inflammatory cells in lung. Eur Respir J 2014; 44: Suppl. 58, 270

Member's Comments

No comment yet.

Related content which might interest you: Effects of two immunosuppressive triple therapies on inflammatory cells in lung Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 The effect of immunosuppression on airway integrity Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Serum cytokines patterns in lung transplant recipients Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Inflammatory response following DCD and DBD lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Fibrocyte involvement and increased prostacyclin and VEGF in the rejection process after lung transplantation Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Does perfusion with the organ care system influence inflammatory response in lung transplantation? Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Effect of enginereed GOLD nanoparticles targeted to mesenchymal cells on inflammatory response Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Determining factors for bronchial healing in lung transplantation Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Elevated levels of prostacyclin and VEGF in the rejection process after lung transplantation Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Long-term outcome of lung recipients: The role of CD4+CD25highCD127- treg Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015